We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ENIC:NYSEEnel Chile S.A. Analysis

Data as of 2026-08-08 - not real-time

$4.54

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Enel Chile S.A. trades at $4.54, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. Across the trailing 30 sessions it gained 4.6%. Relative strength is 56.8 — neutral — and the MACD signal is bullish. The recent range runs from support at $4.30 up to resistance at $4.65.
Valuation screens as undervalued: a P/E of 11.1 sits below the sector average of 19.9. The average analyst target implies 8.3% above today's level. Revenue is contracting at 11.3% on a 12.8% profit margin. The 4.25% dividend yield looks covered by current payout levels.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 23.4%, a beta of 0.97 and a maximum drawdown of 15.3%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 6/10.

Top Market Events

Enel Chile S.A. NYSE:ENIC is one of the Best Undervalued Stocks to Buy Under $5. Enel is trading at a forward price to...Detailed price information for Enersis Chile S.Detailed price information for Enersis Chile S.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 8/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 4.20
  • MACD momentum is positive

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 11.1 versus sector average of 19.9
  • Trading above the 200-day average of 4.20

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • P/E of 11.1 versus sector average of 19.9
  • Analyst targets imply +8.3% versus the current price
  • Revenue contracting at -11.3%

Key Metrics & Analysis

Financial Health

Revenue Growth-11.30%
Profit Margin12.82%
P/E Ratio11.1
ROE11.00%
ROA4.11%
Debt/Equity66.91
P/B Ratio1.2
Op. Cash Flow$1.3B
Free Cash Flow$343.6M
Industry P/E19.9

Technical Analysis

TrendBullish
RSI56.8
Support$4.30
Resistance$4.65
MA 20$4.43
MA 50$4.41
MA 200$4.20
MACDBullish
VolumeIncreasing
Fear & Greed Index94.82

Valuation

Fair Value$0.62
Target Price$4.92
Upside/Downside8.29%
GradeUndervalued
TypeValue
Dividend Yield4.25%

Risk Assessment

Beta0.97
Volatility23.44%
Sector RiskLow
Reg. RiskHigh
Geo RiskHigh
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.